GT Metabolic expands MagDI System with FDA clearance of 50mm magnet
The FDA has cleared GT Metabolic Solutions’ larger, 50mm MagDISystem magnet to complement the system's existing 40mm magnet. This...
top of page
Headlines
Chchd10 protein's regulation of adipose tissue suggests new obesity management strategies
Researchers from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine at the University of Hong Kong (HKUMed), identified...
Research
Journal Watch 26/3/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Palatin's oral MC4R Agonist PL7737 receives FDA Orphan Drug Designation for obesity due to leptin receptor deficiency
Palatin Technologies has announced the FDA has granted "orphan drug" designation to PL7737, an oral treatment that activates the...
AI-powered smartphone app constructs 3D model to accurately predict body fat
Researchers from the University of Cambridge have developed a smartphone app that uses machine learning to accurately determine body...
United Biotechnology and Novo Nordisk agree license for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
The United Laboratories International Holdings Limited’s (TUL) wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd....
Improving GLP-1 drug delivery by fusing the peptide directly to immunoglobulin antibodies
Massachusetts Institute of Technology (MIT) researchers have revealed a drug delivery system that "paints" glucagon-like peptide-1...
OAC and TOS urge FDA to enforce GLP-1s compounding regulations
The Obesity Action Coalition (OAC) and The Obesity Society (TOS) have sent a letter to the FDA, along with more than 20 leading...
Combination of the Allurion Program with low-dose GLP-1 therapy to optimise muscle mass and GLP-1 adherence
Allurion Technologies has announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimise...
Why women experience stronger side effects from GLP-1s
There are fundamental sex-based differences in how weight loss medications interact with human biology, according to a study by Olio...
SOS: Partial weight recurrence after substantial weight loss increases vascular disease
Partial weight recurrence after substantial weight loss was associated with a less favourable cardiovascular risk profile and an...
Biolexis reveals allosteric activation mechanism for the GLP-1 receptor
Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of the...
Chchd10 protein's regulation of adipose tissue suggests new obesity management strategies
Researchers from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine at the University of Hong Kong (HKUMed), identified...
Expert consensus: AI poised to revolutionise the future of BMS ethical considerations must be addressed
An international consensus panel of 68 leading bariatric and metabolic surgery (BMS) from 35 countries has concluded that there are...
Industry
All caught up?
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Events
Tweets
bottom of page